Drospirenone

Drospirenone
Product Description

BAYER AG

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
Biopharmaceutical company
CMO/CDMO
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Agrochemical
API Producer
Biopharmaceutical
Contract Manufacturer
Medical Devices
OTC
Pharmaceutical Company (innovator finished products)
Specifications
  • CAS Registry Number
    67392-87-4
  • Selling Points
    International Approvals/Standards; Place of Origin; Quality Service; Reputation; Sustainability
  • Model
    micro
  • Supplied from
    Germany
  • Measured In
    kilogram

BAYER AG

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
Biopharmaceutical company
CMO/CDMO
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Agrochemical
API Producer
Biopharmaceutical
Contract Manufacturer
Medical Devices
OTC
Pharmaceutical Company (innovator finished products)

More Products from BAYER AG (17)

  • Acarbose
  • Biotechnology Contract Development and Manufacturing

    Product Biotechnology Contract Development and Manufacturing

    Bayer is offering CDMO Services for Biotechnological Products! The Future is Now. Bayer is your reliable Partner for your Innovation. 
    You are looking for a partner to develop and commercialize you biotechnological asset? 
    Whether it is a Protein, a Cell Therapy or Gene Therapy Product...
  • Contract Manufacturing of APIs

    Product Contract Manufacturing of APIs

    Bayer is offering Contract Manufacturing of APIs. At Bayer we offer Contract Manufacturing Services for APIs from our API Manufacturing Sites in Germany, Spain and Mexico with a wide range of capabilities from Classical Chemical Synthesis to Biotransformation including handling and recovery of Solvent...
  • Contract Manufacturing of Drug Products

    Product Contract Manufacturing of Drug Products

    Bayer is offering Contract Manufacturing of Drug Products.With a Global Network of 25 Manufacturing sites, located in JP, ID, CN, IT, DE, US, MX, AR, GT, MA, FI, Bayer has a wide Footprint to support the Manufacturing and Commercialization of your Product. Whether you are looking for a standard plain table...
  • Ethinyl Estradiol
  • Gestodene

    Product Gestodene

    Progestogens
  • Levonorgestrel

BAYER AG resources (8)

  • News Bayer offers Contract Manufacturing!

    You will know Bayer as manufacturer of innovative high-quality API and Drug Products. 

    But do you know that Bayer offers as well Contract Manufacturing?

    Schedule a meeting with us now at CPhI in Frankfurt. We are happy to introduce you to our global manufacturing network with a footprint in Europe, Mexico, China and Japan.

    We offer tailored solutions for your product:From Small Molecules to Large Molecules
    From classical API synthesis to biocatalysis, 
    From formulation of semisolids or tableting to aseptic manufacturing of prefilled syringes.
     

    We look forward to hearing from you

  • Brochure CMO Brochure

    Check out our CMO Brochure to learn more about the capabilities of our global API and DP manufacturing network and so many other excellent reasons to partner with Bayer.
  • News CPHI Podcast Series: analysing supplier audits with the PSCI

    This episode of the CPHI Podcast Series, hosted by Digital Editor Lucy Chard, goes through the results from the recent audits from the PSCI conducted on suppliers across the pharmaceutical industry, looking into ESG outcomes. 

  • News The PSCI introduces the Supplier Maturity Models: a webinar

    The PSCI have launched their framework for suppliers in the pharmaceutical and health industry for increasing social and environmental responsibility, complete with guides and resources, all showcased in a helpful webinar. 

  • News Allyship in Pharma – Building Industry Inclusivity

    Provision of healthcare is an important aspect of people's lives, especially those in the LGBTQIA+ community. Pharmaceutical companies are working to improve this access to medicine and representation for the population. 

  • News CPHI Podcast Series: Celebrating International Women’s Day by championing women’s health

    The March episode of the CPHI Podcast Series is dedicated to celebrating International Women's Day, followng the theme #EmbraceEquity in the context of women's health. 

  • News Viralgen opens expanded AAV manufacturing facility in Spain

    The CDMO's fivefold capacity increase will provide early preclinical through to commercialisation support

  • News Bayer makes €250 million manufacturing investment in Finland

    The company expects to complete its building and modernising plans in Turku by 2025